NCT06100757 - Effect of Leadless Pacing on Heart Function | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

November 30, 2021

Study Completion Date

December 31, 2021

Conditions

Pacing-Induced Cardiomyopathy

Interventions

DEVICE

Micra Transcatheter Pacing System (TPS°

Implantation of a leadless pacemaker type Micra TPS. Echocardiographic and clinical follow-up during 12 months

DEVICE

Conventional pacemaker type Medtronic Advisa ADSR03 or Azure XT VR

Implantation of a conventional ventricular pacemaker (VVI and VV(R) pacing mode) and right ventricular lead (Medtronic 5076-58)/ Echocardiographic and clinical follow-up during 12 months

Trial Locations (1)

3000

University Hospitals of Leuven, Leuven